Zynex (ZYXI) News Today $7.83 -0.12 (-1.51%) (As of 10/3/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Investors in Zynex (NASDAQ:ZYXI) have unfortunately lost 22% over the last five yearsOctober 3 at 3:47 PM | finance.yahoo.comZynex's strategic shifts set stage for long-term success, analysts saySeptember 16, 2024 | proactiveinvestors.comZynex CEO reflects on 28 years of medical device innovation - ICYMISeptember 7, 2024 | proactiveinvestors.comIn spite of recent selling, insiders still have the largest holding in Zynex, Inc. (NASDAQ:ZYXI) with a 51% ownershipSeptember 6, 2024 | finance.yahoo.comBuy Rating Affirmed for Zynex on FDA Clearance and Solid Growth ProspectsSeptember 5, 2024 | markets.businessinsider.comZynex's (ZYXI) "Buy" Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $16.00 price target on shares of Zynex in a research report on Wednesday.September 4, 2024 | marketbeat.comZynex to Present at the HC Wainwright Global Investment ConferenceSeptember 4, 2024 | prnewswire.comZynex Receives FDA Clearance For New TensWave DeviceSeptember 4, 2024 | markets.businessinsider.comZynex pain management device TensWave achieves FDA clearanceSeptember 3, 2024 | proactiveinvestors.comZynex Obtains FDA clearance for new Pain Management DeviceSeptember 3, 2024 | prnewswire.comZynex's bold expansion in patient monitoring technologies moves from vision to realityAugust 20, 2024 | proactiveinvestors.comZynex's (NASDAQ:ZYXI) Returns On Capital Not Reflecting Well On The BusinessAugust 17, 2024 | finance.yahoo.comAnna Lucsok Sells 8,083 Shares of Zynex, Inc. (NASDAQ:ZYXI) StockAugust 10, 2024 | insidertrades.comChief Operating Officer Of Zynex Sold $199K In StockAugust 9, 2024 | benzinga.comInsider Sale: COO Anna Lucsok Sells 24,875 Shares of Zynex Inc (ZYXI)August 9, 2024 | finance.yahoo.comJanus Henderson Group PLC Sells 76,126 Shares of Zynex, Inc. (NASDAQ:ZYXI)Janus Henderson Group PLC cut its stake in shares of Zynex, Inc. (NASDAQ:ZYXI - Free Report) by 72.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,781 shares of the company's stock after seAugust 8, 2024 | marketbeat.comWednesday 7/31 Insider Buying Report: ZYXI, HTBIAugust 2, 2024 | nasdaq.comSell Alert: Daniel Moorhead Cashes Out $123K In Zynex StockJuly 31, 2024 | benzinga.comZynex, Inc. (NASDAQ:ZYXI) Director Purchases $58,240.00 in StockJuly 31, 2024 | insidertrades.comHC Wainwright Analysts Reduce Earnings Estimates for Zynex, Inc. (NASDAQ:ZYXI)Zynex, Inc. (NASDAQ:ZYXI - Free Report) - HC Wainwright cut their Q1 2025 earnings per share (EPS) estimates for Zynex in a report issued on Friday, July 26th. HC Wainwright analyst Y. Chen now expects that the company will post earnings of $0.10 per share for the quarter, down from their previouJuly 29, 2024 | marketbeat.comZynex (NASDAQ:ZYXI) Issues Earnings Results, Misses Expectations By $0.04 EPSZynex (NASDAQ:ZYXI - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.04). Zynex had a return on equity of 16.34% and a net margin of 4.33%. The firm had revenue of $49.88 million during the quarter, compared to the consensus estimate of $51.99 million. During the same period in the previous year, the firm earned $0.09 EPS. The business's revenue was up 11.0% on a year-over-year basis.July 26, 2024 | marketbeat.comWhy Zynex Plunged TodayJuly 26, 2024 | fool.comZynex (NASDAQ:ZYXI) Price Target Cut to $12.00 by Analysts at Royal Bank of CanadaRoyal Bank of Canada dropped their price objective on Zynex from $15.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday.July 26, 2024 | marketbeat.comZynex, Inc. (NASDAQ:ZYXI) Q2 2024 Earnings Call TranscriptJuly 26, 2024 | msn.comWhy Is Zynex (ZYXI) Stock Down 24% Today?July 26, 2024 | investorplace.comZYXI Stock Earnings: Zynex Misses EPS, Misses Revenue for Q2 2024July 25, 2024 | markets.businessinsider.comZynex Shares Drop 18% After 2Q Earnings Miss, Outlook CutJuly 25, 2024 | marketwatch.comZynex Reports Second Quarter 2024 Financial ResultsJuly 25, 2024 | prnewswire.comHere's what Wall Street expects from Zynex's earnings reportJuly 25, 2024 | markets.businessinsider.comZynex Q2 2024 Earnings PreviewJuly 24, 2024 | msn.comZynex Sets Second Quarter 2024 Earnings CallJuly 17, 2024 | prnewswire.comZynex Recognized as a Best Company to Work For by U.S. News & World Report and Top WorkplacesJuly 11, 2024 | prnewswire.com7 Short Squeeze Stocks to Look Into for Your PortfolioIn 2021, a trader with a large Reddit following induced a massive rally in shares of GameStop Corp. NYSE: GME. The downtrodden gaming retailer was the most shorted stock in the entire market in January 2021, but the retail buying frenzy triggered a massive run-up in price as hedge funds were forced to cover their short positions to prevent huge losses.June 27, 2024 | marketbeat.com3 Short-Squeeze Stocks Poised for a Jaw-Dropping RallyJune 24, 2024 | investorplace.comAnalyst Predictions: 3 Stocks Pegged to Soar Over 40% in One YearJune 19, 2024 | investorplace.comZynex (NASDAQ:ZYXI) Stock Rating Reaffirmed by Royal Bank of CanadaRoyal Bank of Canada reaffirmed an "outperform" rating and issued a $15.00 target price on shares of Zynex in a report on Friday.June 14, 2024 | marketbeat.comZynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024June 10, 2024 | prnewswire.comHere's Why We Think Zynex, Inc.'s (NASDAQ:ZYXI) CEO Compensation Looks FairMay 10, 2024 | finance.yahoo.comLSV Asset Management Makes New $818,000 Investment in Zynex, Inc. (NASDAQ:ZYXI)LSV Asset Management acquired a new stake in Zynex, Inc. (NASDAQ:ZYXI - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 75,095 shares of the company's stock, valued at approxMay 10, 2024 | marketbeat.comZynex to Present at the RBC Capital Markets Global Healthcare ConferenceMay 9, 2024 | prnewswire.comZynex Executives Recognized Among Top 25 in Medical TechnologyMay 7, 2024 | prnewswire.comZynex, Inc. (NASDAQ:ZYXI) to Post Q3 2024 Earnings of $0.16 Per Share, HC Wainwright ForecastsZynex, Inc. (NASDAQ:ZYXI - Free Report) - Analysts at HC Wainwright upped their Q3 2024 earnings per share (EPS) estimates for shares of Zynex in a research note issued on Wednesday, May 1st. HC Wainwright analyst Y. Chen now expects that the company will post earnings of $0.16 per share for theMay 3, 2024 | marketbeat.comZynex, Inc. (NASDAQ:ZYXI) Q1 2024 Earnings Call TranscriptMay 2, 2024 | finance.yahoo.comQ2 2024 EPS Estimates for Zynex, Inc. (NASDAQ:ZYXI) Decreased by AnalystZynex, Inc. (NASDAQ:ZYXI - Free Report) - Equities researchers at HC Wainwright reduced their Q2 2024 earnings per share estimates for shares of Zynex in a note issued to investors on Wednesday, May 1st. HC Wainwright analyst Y. Chen now expects that the company will post earnings per share of $0May 2, 2024 | marketbeat.comZynex Inc (ZYXI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Seizing ...May 2, 2024 | finance.yahoo.comZYXI Stock Earnings: Zynex Misses Revenue for Q1 2024April 30, 2024 | msn.comZynex (NASDAQ:ZYXI) Updates Q2 2024 Earnings GuidanceZynex (NASDAQ:ZYXI) updated its second quarter 2024 earnings guidance. The company provided EPS guidance of 0.080- for the period, compared to the consensus estimate of 0.070. The company also issued revenue guidance of $52.0 millionillion-, compared to the consensus estimate of $53.1 millionillion.April 30, 2024 | marketbeat.comZynex Inc (ZYXI) Q1 2024 Earnings: Revenue Meets Expectations, EPS Falls ShortApril 30, 2024 | finance.yahoo.comZynex Reports First Quarter 2024 Financial ResultsApril 30, 2024 | prnewswire.comWhat Wall Street expects from Zynex's earningsApril 29, 2024 | markets.businessinsider.com Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. ZYXI Media Mentions By Week ZYXI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZYXI News Sentiment▼-1.140.58▲Average Medical News Sentiment ZYXI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZYXI Articles This Week▼12▲ZYXI Articles Average Week Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cutera News Pulse Biosciences News Bioventus News National Vision News MiMedx Group News Embecta News Perspective Therapeutics News Liquidia News OrthoPediatrics News Iradimed News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZYXI) was last updated on 10/3/2024 by MarketBeat.com Staff From Our PartnersWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.